Lecture 17: Antihypertensives Flashcards
Current Treatments
- First-line agents: ACE-inhibitors, ARBs, calcium channel blockers, thiazide diuretics
- Second-line agents: Beta-blockers, aldosterone antagonists
- Other agents: Loop diuretics, alpha-blockers, direct vasodilators, central alpha2-agonists, renin inhibitors

Antihypertensives classes
- Inhibitors of angiotensin (ACE-inhibitors / ARBs / renin inhibitors)
- Calcium-channel blockers
- Diuretics
- Beta-adrenoceptor antagonists
- alpha-adrenoceptor antagonists
- Central alpha2 agonists
- Direct vasodilators
ACE Inhibitors
- Captopril, Enalapril, Lisinopril
- First-line agents (in particular for diabetics and patients w chronic kidney disease)
- decr BP by decr peripheral vascular resistance
- INHIBIT ACE (angiotensin converting enzyme) that cleaves angiotensin I to form angiotensin II
- DECREASE Na+ & H20 retention
- INCREASE BRADYKININ levels
- DO NOT reflexively increase cardiac output, rate or contractility
Use
- Hypertension (most effective in white and/or young patients) + diuretic = effectiveness similar in white and black
- Preserve renal function in patients with either diabetic or non-diabetic nephropathy
- Effective in treatment of chronic HF
- Standard of care for patients following MI (started 24h after end of infarction)
Adverse
- Hyperkalemia
- Hypotension
- Persistent Dry cough
- Teratogenic
- Angioedema (rare but life-threatening)
- Acute renal failure (patients with bilateral renal artery stenosis RAS); However, ACE inhibitor is the drug of choice for unilateral
- Rash, fever, altered taste
- ABSOULTE contraindication in pregnancy
Angiotensin Receptor Blockers (ARB)
- Block angiotensin-2 type 1 receptors
- BP by causing arteriolar & venous dilation
- Block aldosterone secretion -> decrease Na+ & H20 retention
- diabetic nephrotoxicity
- DO NOT INCREASE BRADYKININ levels
- Antagonism of aldosterone receptor -> inhibition of Na+ and H20 retention -> inhibition of vasoconstriction
- Reduces K+ excretion -> risk of hyperkalemia (more prominent in patients with chronic kidney disease or in patients taking concurrent ACEI, ARB or other K+-sparing diuretics)
- Used in the treatment of hypertension & heart failure
- Can be used as part of first-line therapy in patients with hypertension & severe left ventricular dysfunction
Adverse
- Similar to those of ACE inhibitors
- Dry cough does not occur (due to no effect on bradykinin levels)
- Angioedema risk is significantly lower than with ACEI’s
- contraindicated in pregnancy
- contraindicated in Pt w bialteral RAS
Renin Inhibitor
- Ex. Aliskerin
- MOA: Inhibits enzyme activity of renin and prevents conversion of angiotensinogen into angiotensin I
- End result: Inhibits production of both angiotensin II and aldosterone
Adverse
- Similar to those of ACE inhibitors
- hyperkalemia
- Dry cough does not occur (due to no effect on bradykinin levels)
- Angioedema risk is significantly lower than with ACEI’s
Ca2+ Channel Blockers (CCB)
- Verapamil, Diltiazem, Nifedipine, Amlodipine
- First-line agents
- Ca2+ CHANNEL CLASSES
- Non-dihydropyridines
- Verapamil
- Diltiazem
- Dihydropyridines
- Nifedipine, Amlodipine
Uses
- HPT
- have intrinsic natriuretic effect
- Useful in patients with asthma, diabetes, peripheral vascular disease
PK
- High-doses of short-acting dihydropyridine Ca2+- channel blockers can increase risk of MI (excessive vasodilation & reflex cardiac stimulation)
- Sustained release preparations are preferred
Adverse
- Verapamil: Constipation (~7 %), should be avoided in patients with CHF (-ve inotropic effects)
- Dihydropyridines: Hypotension, peripheral edema (esp. feet & ankles), dizziness, headache, fatigue, bradycardia, heart block, reflex tachycardia can occur, especially in short-acting preparations

Verapamil
- Least selective of any Ca2+-blocker
- Significant effects in cardiac & vascular smooth muscle
- Used to treat angina, supraventricular tachyarrythmias, hypertension & migraine
Dilitiazem
- Effects in both cardiac & vascular smooth muscle (less pronounced effect on heart than verapamil)
- Good side-effect profile
- Used to treat angina, hypertension & supraventricular tachyarrythmias
Dihydropyridines
- 1st gen: Nifedipine
- 2nd gen: Amlodipine
- Greater affinity for vascular Ca2+-channels than for cardiac Ca2+-channels
- Reduce Ca2+ entry into smooth muscles to cause coronary & peripheral vasodilatation & lower BP
- Primarily used in treating hypertension
Diuretics: Thiazides
- First-line agents (particularly black and/or elderly patients)
- Effective in lowering BP by 10-15 mmHg
MOA
- Lower BP by incr Na+ and H20 excretion -> decr in extracellular volume -> decr in cardiac output & renal blood flow.
- Long-term treatment = normal plasma volume but decreased peripheral resistance
Uses
- Counteract Na+ & H20 retention caused by other antihypertensive drugs -> useful in combination therapy
- Particularly useful in black & elderly (with normal renal & cardiac function)
Adverse
- Hypokalemia
- Hyperuricemia
- Hyperglycemia
- Hypomagnesemia
- Hypercholesterolemia
Loop diuretics
- Act promptly in patients with poor renal function or heart failure
- More potent at inducing diuresis & can cause more side effects
- Used primarily in patients who do not respond to thiazide therapy adequately
- Cause decr renal vascular resistance & incr renal blood flow
Potassium-Sparing
- decr K+ loss in urine caused by thiazide or loop diuretics
- Used in combination
Beta-blockers
- Propranolol, Metoprolol, Atenolol, Pindolol
- Used only as add-on therapy to first line agents in primary prevention patients
- First-line therapy only for patients with coronary artery disease, heart failure or post-MI
alpha1-blockers
- Prazosin, Doxazosin
- Na+ & H20 retention does occur
- Effective in lowering BP but more side effects than other antihypertensives
- Hypertension (due to side-effect profile, development of tolerance & advent of safer antihypertensives, alpha- blockers are seldom used in treatment of hypertension)
Adverse
- Orthostatic hypotension (which may lead to syncope) upon first-dose or large increases in dose
- Concomitant use of a Beta-blocker may be necessary to blunt short-term effect of reflex tachycardia
- Dizziness, drowsiness, headache, lack of energy, nausea, and palpitations,
- Doxazosin shown to incr rate of CHF
- reflex tachycardia
Labetalol
- Oral & parenteral admin.
- Used in hypertension management (safe in pregnancy)
- IV labetalol = rapid reduction in BP -> useful in hypertensive emergencies
- Advantages: decr in BP associated with alpha1-blockade is not associated with reflex increase in HR or cardiac output
Clonidine
- DOES NOT decr renal blood flow or GFR
- Used in hypertension management, including hypertensive crises (other drugs with fewer side effects are now generally preferred)
- Drowsiness, dry mouth, dizziness, headache & sexual dysfunction occur commonly
- Rebound hypertension may occur following abrupt withdrawal (avoid concomitant use with Beta-blockers)
Methyldopa
- DOES NOT decr renal blood flow or GFR
- Usually treatment of choice for pregnancy-induced hypertension
- Used in hypertension management (other drugs with fewer side effects are now generally preferred)
Adverse
- Nightmares, mental depression, vertigo (infrequent)
- Development of positive Coombs test (10-20% patients on long-term treatment (>1 year)). Can result in hemolytic anemia, hepatitis & drug fever
Direct vasodilators
- Hydralazine, Minoxidil
- Not used as first-line antihypertensives
- Direct acting smooth muscle relaxants
- Produce reflex tachycardia, increase plasma renin -> Na+& H20 retention
- Major side effects can be blocked if combine with diuretic & beta-blocker
Hydralazine
- Can be given oral or IV
- Acts mainly on arterioles
- Used to treat pregnancy induced hypertension / pre- eclampsia, ie emergency situations
- Used in management of hypertension as last-line therapy
Adverse
- Fluid retention & reflex tachycardia are common
- Reversible lupus-like syndrome
- Headache, nausea, sweating, flushing
- peripheral neuritis
- Usually administered with beta-blocker & thiazide
Minoxidil
- Causes direct peripheral vasodilatation of arterioles
- Oral treatment for severe-malignant hypertension (refractory to other treatments)
- Reflex tachycardia & fluid retention may be severe (combine with loop diuretic & beta-blocker)
- Causes hypertrichosis (also used topically to treat male pattern baldness)
Epoprostenol
- Synthetic PGI2
- Lowers peripheral, pulmonary, and coronary resistance
- Given via continuous infusion
- Adverse effects include flushing, headache, jaw pain, diarrhea and arthralgias
Bosentan
- Nonselective endothelin receptor blocker
- Blocks both the initial transient depressor (ETA) and the
- prolonged pressor (ETB) responses to IV endothelin • Pregnancy category X
Causes of Hypertensive Emergency (partial list)
- Drug withdrawal eg, clonidine, nifedipine etc.
- CNS disorders eg, injury, stroke, tumor
Hypertensive Emergency: Management
(a) Lower BP by no more than 25 % (within min – 1 h). Appropriate goal is 100-110 mmHg (DBP)
(b) If stable, followed by further reduction towards goal of 160/100 mmHg (SBP/DBP) within 2-6 h and gradual reduction to normal over next 8-24 h
- Sodium nitroprusside
- Labetalol
- Fenoldopam
- Nicardipine
- Nitroglycerin
- Diazoxide
- Phentolamine
- Esmolol
- Hydralazine
Sodium Nitroprusside
- Drug of choice for hypertensive emergencies
- Always given IV (poisonous if given orally)
- t1/2 = 1-2 min ->requires continuous infusion
- NO releaser
- Prompt vasodilation &
- Equal effect on arterial & venous smooth muscle
Adverse
- Hypotension (overdose), goose bumps, abdominal cramping, nausea, vomiting, headache
- Cyanide toxicity (rare)
- Nitroprusside metabolism -> cyanide ion
- Can be treated with sodium thiosulfate infusion -> nontoxic thiocyanate
- reflex tachycardia
Labetalol
- Combined alpha and beta blocker
- IV bolus or infusion for hypertensive emergency
- t1/2 =3-6h
- DOES NOT cause reflex tachycardia
Contraindications
Asthma, COPD, patients with 2nd or 3rd-degree AV block or bradycardia
Fenoldopam
- Peripheral dopamine-1 (D1) receptor agonist
- Evokes arteriolar dilation
- IV infusion for hypertensive emergency
- t1/2 = 30 min
- Maintains or increases renal perfusion as lowers BP
- Promotes naturesis
- Safe to use in all hypertensive emergencies (particularly beneficial in patients with renal insufficiency)
- Contraindications: Glaucoma
Nicardipine
- Calcium-channel blocker
- IV infusion for hypertensive emergency
- t1/2 = 30 min
- Evokes reflex tachycardia
Nitroglycerin
- Venous and arterial and vasodilator
- Drug of choice for hypertensive emergencies in patients with cardiac ischemia or angina, or after cardiac bypass surgery
- t1/2 = 2-5 min
- Hypotension = most serious side effect
Diazoxide
- Arteriolar dilator
- Prevents vascular smooth muscle contraction by opening K+ channels and stabilizing membrane potential
- t1/2 =~24h
Adverse Effects:
- Hypotension, reflex tachycardia, Na+ & H20 retention
- Inhibits insulin release and can be used to treat hypoglycemia secondary to insulinoma